Subtotal
$0.00
Shipping
$0
Taxes
$0
Total
$0.00
LuciBriga 180mg
LuciBriga 180mg
$494.93
$600.00
LuciBriga is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
Qty
COMPOSITION:
Each film-coated tablet contains Brigatinib……………………………. 180 mg
INDICATION:
LuciBriga is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
DOSAGE AND USE:
90 mg orally once daily for the first 7 days; then increase to 180 mg orally once daily.
May be taken with or without food.
STORAGE:
in a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY:
LUCIUS PHARMACEUTICALS(LAO) CO., LTD
No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING:
Keep medicine out of reach of Children. Do not administer LuciBriga during Pregnancy and Lactation\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Customer Reviews
Based on 1 review
Write a review
Write a review
Cobus Bester
Cobus Bester on Mar 03, 2023
Can’t wait to start mixin’ with this one! Irba-irr-Up-up-up-up-date your theme!
Report as InappropriateRelated Products
.jpeg)
.jpg)
